ArticleMovement disorders : official journal of the Movement Disorder Society2025
Compound Heterozygous Structural Variants in Cases with Unsolved PRKN-Associated Parkinson's Disease.
Article in Movement disorders : official journal of the Movement Disorder Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
backgroundBiallelic mutations in the PRKN gene are a common cause of early-onset Parkinson's disease (EOPD). In addition to single nucleotide variants, structural variants contribute substantially to the mutational profile of PRKN. A significant portion of patients with EOPD remains genetically unsolved.
objectivesBy using short-read whole genome sequencing (sr-WGS), we aimed to uncover complex genetic alterations at the PRKN locus in EOPD cases which tested negative for mutations in Mendelian PD genes with clinical exome sequencing (CES) and multiplex ligation-dependent probe amplification (MLPA).
methodsWe evaluated 498 unrelated EOPD patients, who tested negative using gold-standard diagnostic methods, using sr-WGS. In selected cases, long-read whole genome sequencing (lr-WGS) with Oxford Nanopore technology was employed for an in-depth analysis and validation. The Parkinson's Progression Markers Initiative (PPMI) dataset was interrogated to assess the prevalence of any newly identified elusive pathogenic genetic configurations.
resultssr-WGS revealed elusive compound heterozygous structural variations, consisting of partially overlapping deletions and duplications within the PRKN gene in three unrelated EOPD cases (two familial, one sporadic). In familial cases, biallelic PRKN structural variants co-segregated with the disease. The exact structure of each variant was resolved using lr-WGS. Similar variants were absent in the large PPMI database, suggesting that they are a rare occurrence.
conclusionsIn this article we describe a rare configuration of compound heterozygous structural variations involving partially overlapping chromosomal regions at the PRKN locus, which are difficult to detect through standard diagnostic genetic technologies. This study highlights the importance of integrating WGS into clinical practice. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.